Captisol (SBE-β-CD)
Captisol (SBE-β-CD) (CAS No.: 182410-00-0) is a chemically modified beta cyclodextrin derivative in the sulfobutyl ether class, categorized in biomedical research primarily as a pharmaceutical excipient and solubilizing carrier for poorly water soluble bioactive molecules, with a nonbiological synthetic origin and a functional design that combines a hydrophobic cavity for reversible inclusion of lipophilic regions of guest compounds with charged substituents that improve aqueous compatibility, thereby supporting formulation stability, dispersion behavior, and experimental reproducibility across discovery workflows. In mechanistic terms, its principal action is physicochemical rather than receptor driven, as it typically does not function as a direct high affinity ligand for canonical protein targets or signaling nodes but instead modulates apparent compound exposure, free fraction, and transport related behavior in assay systems through host guest complexation and microenvironmental effects, which can secondarily influence readouts in pathways such as kinase, GPCR, ion channel, and nuclear receptor assays by changing analyte availability rather than by pathway specific agonism or antagonism. Consistent with this role, direct in vitro potency metrics such as IC50, EC50, or MIC are generally not defining parameters for the carrier itself, while activity outcomes for formulated payloads are often reported across nanomolar to micromolar response ranges depending on the associated active molecule, matrix conditions, and analytical format. In practice, it is broadly applied in cell based testing, biochemical screening, and preclinical animal study formulations as a co solvent and stabilization component to enable dose preparation and improve handling of insoluble candidates, including use in early ADME and pharmacology support studies where improved dispersion can reduce precipitation artifacts; the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives, with selection guided by compatibility, control performance, and study specific tolerability in the relevant experimental system.
| Storage | -20°C for 3 years |
| M.Wt | 2083-2257 |
| Cas No. | 182410-00-0 |
| Synonyms | Sulfobutylether-β-Cyclodextrin |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |






